Nurofen maker RB defends UK advertising claims as ASA investigates
The Advertising Standards Authority is formally investigating Nurofen maker Reckitt Benckiser in the UK after receiving 12 complaints about a TV ad for Nurofen Express.
Complainants have taken issue with claims the product can provide “faster headache relief than standard paracetamol or ibuprofen” and that it can directly target muscles in the head.
A spokesperson for the ASA says: “This is a complex case and our investigation is ongoing. The advertiser is providing evidence to substantiate its claims, we’re carefully assessing that and we’ll publish our findings in due course.”
However, RB has highlighted that all claims made in ads in the UK Read full story ›
Source: Marketing Week
